Package 39822-0650-6

{"route": ["INTRAVENOUS"], "spl_id": "298c4520-5858-7ce6-e063-6394a90a0531", "openfda": {"nui": ["N0000000233", "N0000175595"], "upc": ["0339822065011"], "unii": ["60158CV180"], "rxcui": ["603566"], "spl_set_id": ["a1cc1580-50d9-4b9b-a002-1fc6686a9515"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["XGen Pharmaceuticals DJB, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (39822-0650-1)  / 50 mL in 1 VIAL", "package_ndc": "39822-0650-1", "marketing_start_date": "20250217"}, {"sample": false, "description": "6 VIAL in 1 CARTON (39822-0650-6)  / 50 mL in 1 VIAL", "package_ndc": "39822-0650-6", "marketing_start_date": "20250217"}], "brand_name": "Nelarabine", "product_id": "39822-0650_298c4520-5858-7ce6-e063-6394a90a0531", "dosage_form": "INJECTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "39822-0650", "generic_name": "Nelarabine", "labeler_name": "XGen Pharmaceuticals DJB, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Nelarabine", "active_ingredients": [{"name": "NELARABINE", "strength": "5 mg/mL"}], "application_number": "ANDA216510", "marketing_category": "ANDA", "marketing_start_date": "20250217", "listing_expiration_date": "20261231"}